SCHEMBL9301817

SCHEMBL9301817

CCOP(=O)(O)C(N1CCC(O)CC1)P(=O)(O)O

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.38
TSHR P16473 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
PPARD Q03181 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5075884 0.87 FDPS (0.45) FDPSTSHRPPARD
SCHEMBL6670360 0.87 FDPS (0.45) FDPSTSHRPPARD
SCHEMBL22991393 0.82 POLB (0.33) TSHRMMP1MMP2
SCHEMBL9301764 0.81 FDPS (0.44) FDPSMMP1MMP2
SCHEMBL9301484 0.79 FDPS (0.58) FDPS
SCHEMBL9658935 0.79 FDPS (0.32) FDPS
SCHEMBL9300979 0.78 OPRM1 (0.49)
SCHEMBL9302643 0.78 FDPS (0.38) FDPSTSHRPPARD
SCHEMBL9301258 0.78 FDPS (0.38) FDPSTSHRPPARD
SCHEMBL9302623 0.77 FDPS (0.37) FDPSTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed